5/18
Coronavirus Research
Hospitalizations for eating disorder increased during pandemic
Researchers can’t yet pinpoint definitive reasons, though they surmise it was a combination of factors, including stress, an outsized focus on weight gain and personal appearance, and maybe even symptoms of COVID-19 itself.
How observation units and texting shortened hospital stays during COVID-19
An analysis of hospital care for COVID-19 patients shows that while short hospitalizations were often unavoidable, it is be possible to expedite the discharge for patients who could continue to recover at home, with some additional clinical support from the health system.
A chewing gum that could reduce SARS-CoV-2 transmission
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists.
Sharon Wolf’s work in Ghana expands to address pandemic-related inequalities
The assistant professor at Penn GSE applies research of children, their primary caregiver, and teachers throughout the pandemic about their experiences with remote schooling to a new approach in controlling learning opportunities before gaps in learning form.
With more kids eligible for vaccines, is the pandemic in a new phase?
With the FDA authorization last week, 28 million more children are eligible to be vaccinated against COVID-19. Experts from the School of Nursing and Perelman School of Medicine share their thoughts about what to expect in the weeks and months to come.
A hub for zoonotic disease research
The new Institute for Infectious and Zoonotic Diseases, launched by the School of Veterinary Medicine, leans on Penn’s strengths in immunology and infectious disease to prepare for emerging threats to animal and human health.
Four facts about the COVID-19 boosters
The FDA and CDC endorsed boosters of the Moderna and Johnson & Johnson COVID-19 vaccines just a month after the agencies did the same for a Pfizer/BioNTech booster. Here’s what’s known today about these shots.
Mandates likely work to increase vaccine uptake
Rather than causing a backlash, vaccination requirements will succeed at getting more people inoculated, according to research from PIK Professor Dolores Albarracín and colleagues at Penn.
Drew Weissman and Katalin Karikó receive 2021 Lasker Award
Weissman and Karikó’s mRNA technology is recognized for enabling rapid development of highly effective COVID-19 vaccines
At-home COVID-19 results with the click of a smartphone
Penn researchers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →